- Key Insights: The NASDAQ has entered a historically oversold state, presenting
a high-probability opportunity for a short-term rebound. While bearish
signals persist due to recent momentum shifts, long-term institutional
activity indicates underlying support. Traders should look for defensive
buying near support zones to capitalize on upward moves. Critical levels
must be monitored closely for confirmation.
- Price Targets:
- Next Week Targets:
- T1: 21,000
- T2: 21,479
- Stop Levels:
- S1: 20,426
- S2: 20,250
- Recent Performance: The NASDAQ has faced four consecutive days of declines,
breaking below key technical levels that signal bearish pressures. However,
institutional support and broader bullish indicators remain intact, keeping
the index positioned as the strongest major U.S. equity index in the longer
term. Historically oversold conditions provide optimism for a potential
bounce next week.
- Expert Analysis: Despite short-term bearish momentum, expert outlook continues
to align with NASDAQ’s long-term resilience above major moving averages.
Institutional liquidity flow and ongoing interest in technology continue to
support the index, though caution is warranted around immediate support
barriers to avoid deeper pullbacks. Monitoring liquidity gaps is crucial.
- News Impact: NVIDIA earnings are anticipated to be a pivotal event next week
and could drive volatility in NASDAQ tech sectors depending on the outcome.
Elevated volatility levels, as evidenced by the VIX, further warrant caution
while underscoring potential opportunities for rebound plays. Additionally,
NASDAQ’s move to expand zero-day options trading has drawn mixed responses
but could influence short-term speculative activity in its top tech stocks
like Apple, Microsoft, Amazon, and Alphabet.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.